Related Experiment Videos
Development of a homogeneous binding assay for histamine receptors
1Department of Immunology and Immunological Diseases, Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT 06877, USA.
Analytical Biochemistry
|November 3, 2004
Summary
A new scintillation proximity assay (SPA) enables high-throughput screening of compounds targeting histamine receptors. This advanced method simplifies drug discovery for conditions linked to histamine signaling.
Area of Science:
- Pharmacology
- Biochemistry
- Drug Discovery
Background:
- Histamine receptors (H1-H4) are crucial in physiological and pathological processes.
- Targeting histamine receptors offers therapeutic potential for allergies, gastric acid secretion, obesity, neurological disorders, and inflammatory diseases.
Purpose of the Study:
- To develop a novel, high-throughput screening assay for histamine receptor ligands.
- To replace the traditional, low-throughput filtration assay with a more efficient method.
Main Methods:
- Utilized scintillation proximity assay (SPA) technology.
- Developed a homogeneous binding assay adaptable to automation.
Main Results:
- The SPA assay demonstrated robustness and simplicity.
- Achieved results equivalent to the conventional filtration assay.
- The assay is suitable for high-throughput screening (HTS) of compounds against histamine receptors.
Conclusions:
- The developed SPA assay facilitates efficient drug discovery for histamine receptor-related targets.
- This method accelerates the identification of novel therapeutic agents by enabling HTS.
- The SPA assay supports screening against multiple histamine receptors simultaneously.